Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
723
NCT03220633
Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2014
Completion: Dec 31, 2014
NCT03291418
To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects
Phase: Phase 1/2
Start: Sep 8, 2017
Completion: Apr 30, 2018
NCT03978208
Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients
Phase: Phase 2
Start: Mar 29, 2019
Completion: Dec 29, 2019